FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2–induced resistance

Westover, D., Ling, X., Lam, H., Welch, J., Jin, C., Gongora, C., Del Rio, M., Wani, M., & Li, F. (2015). FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2–induced resistance. Molecular Cancer, 14(92), 1 - 11.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Modulation of relapse-like drinking in male Sprague-Dawley rats by ligands targeting the α5GABAA receptor
Article

Food, energy, and water nexus research in Guatemala – A systematic literature review
Article

A randomized phase II remote study to assess Bacopa for Gulf War Illness associated cognitive dysfunction